In 2023, the mortality rate for prostate malignant neoplasms in Japan was slightly below the 2024 forecast of 22.4 male deaths per hundred thousand men. Over the forecasted period, the mortality rate shows a steady annual increase, ranging from 22.4 in 2024 to 24.0 in 2028. The year-on-year growth rate in mortality is approximately 1.8% each year. The compound annual growth rate (CAGR) over this 5-year forecast period is estimated at 1.8%, suggesting a persistent upward trend.
Future trends to watch for include the impact of advancements in early detection and treatment options, which could potentially modify these projected mortality rates. Additionally, demographic shifts, such as an aging population, may influence these figures further.
